INDIAN NEWS & TIMES

Friday, October 7, 2022

The Federation of Indian Chambers of Commerce and Industry (FICCI) announced the launch of Self-Regulatory Code of Conduct for e-Diagnostics in India yesterday through a virtual event. The code of conduct was launched in the esteemed presence of Ms Manmeet K Nanda, Joint Secretary, Department for Promotion of Industry and Internal Trade, Government of India. The virtual event was also attended by representatives of health-tech companies, start-ups, non-profits, public -policy scholars, and media professionals.   

Self-Regulatory Code of Conduct for e-Diagnostics – prepared after several rounds of industry consultations by FICCI’s e-Pharmacy working Group aims to ensure adherence to the highest professional standards while delivering quality e-Diagnostic services till last mile in a safe and compliant manner.  

In recent times, the country has seen rapid strengthening of the healthcare network, active participation from all the concerned stakeholders with adequate handholding driven by optimistic policy making with programs like Ayushman Bharat Digital Mission (ABDM). This model fits well with the ‘Ayushman Bharat Digital Mission’ and ‘Atmanirbhar Bharat Abhiyaan’ and encompasses the vision of ‘Digital India’. 

Tech-enabled platforms are playing a significant role in enhancing access to quality healthcare services including diagnostic services by bringing these services to the doorstep furthering the patient centric approach and at home care. The also provide for tracking and traceability of the services aimed to be provisioned from over their platforms. 

To ensure standardization of services along with quality maintenance the industry has taken a welcome step to adhere to the FICCI Self-Regulatory Code of Conduct for e-Diagnostics. FICCI believes that the industry submitting itself to self-regulation, would achieve the dual purpose of structured growth and consumer protection.